effects at the aberrant crypt stage of tumorigenesis (5) . The Butyrate, a short chain fatty acid produced in the colon, short chain fatty acid butyrate, a colonic fermentation product induces apoptosis in cancer cell lines by a sequential process of dietary polysaccharides, partly mediates their protective involving inhibition of histone deacetylase, de novo protein action (6) and is thought to protect via modulation of expression synthesis and activation of DEVD-caspase, a major effector of colonic epithelial genes involved in cell cycle arrest, of apoptotic DNA fragmentation and membrane blebbing.
differentiation and apoptotic cell death. Butyrate is a potent We now show, in LIM 1215 colorectal cancer cells, that inducer of apoptosis in CRC and other cancer cell lines at butyrate, in addition to activating DEVD-caspase and physiological concentrations (7) (8) (9) ). Butyrate appears not to be inducing apoptosis, also increases expression and cleavage toxic for normal colonocytes (4) , perhaps because it is rapidly of the universal cyclin-dependent kinase inhibitor metabolized (as a fuel) by these cells (10) . p21 Waf1/Cip1 and leads to hypo-phosphorylation of retinoOne of the earliest cellular effects of butyrate is hyperblastoma protein. Accompanying these molecular changes acetylation of histones resulting in altered patterns of gene was a progressive loss of G 0 /G 1 and S phase cells. Expression expression. Hyper-acetylation, due to non-competitive inhibiof p21 had similar kinetics to that of the essential protein tion of histone deacetylase, occurs within 30 min in vitro, as required for DEVD-caspase activation, indicating parallel well as in vivo, where high fiber diets promote histone hypereffects of butyrate on anti-apoptotic and pro-apoptotic acetylation in colonic epithelia of rats (11) . That histone mechanisms. LIM 1215 cells, which were resistant to acetylation triggers induction of apoptosis by butyrate is butyrate-induced apoptosis, were selected by three cycles supported by our finding that trichostatin A, a more specific of exposure to butyrate and removal of floating apoptotic inhibitor of histone deacetylase, mimics butyrate in the kinetics cells. These cells showed markedly enhanced p21 expression of induction of apoptosis in colon cancer cells (9). Acetylation and were in cell cycle arrest as determined by flow cytomeof core histones H3 and H4 weakens their association with try. On the other hand, subsequent culture of these cells DNA, thereby promoting transcription factor binding to regufor 2-3 days in the absence of butyrate resulted in downlatory elements of genes and enhancing gene expression regulation of p21 and restoration of sensitivity to apoptosis (12, 13) . Included in this may be one or more cell death by butyrate. Western blots of butyrate-treated cells undergenes (which presumably are normally tightly repressed) since going apoptosis consistently demonstrated a 15 kDa band butyrate-induced apoptosis is blocked by inhibitors of RNA (p15) that was not present in control cultures. This band and protein synthesis (9). became apparent immediately after the onset of DEVDPrincipal amongst the downstream effector molecules in caspase activation, was enriched in the floating apoptotic apoptosis is the family of caspases which cleave certain critical cell population when compared with the adherent, nontargets, leading to either inactivation of the function of the apoptotic cells and was absent in butyrate-resistant cells protein or generation of a pro-apoptotic cleavage product (14-lacking DEVD-caspase activity. Peptide caspase inhibitors 16). Cleavage occurs next to D (Asp) but different caspases partially blocked appearance of p15. Here we show, for may have different substrate specificities. Caspase-3 cleaves the first time, that p21 is a target of effector caspases in after a DXXD motif (X is any of a subset of amino acids) colorectal cancer cells and that the resistance to butyrate- (17) . In one cellular substrate, cleavage is next to DEVD and, induced apoptosis is characterized by failure of p21 therefore, a fluorogenic substrate assay for caspase-3 has been cleavage.
developed based on liberation of a leaving group AFC from DEVD-AFC (associated with an increase in green fluorescence). Although this has been used as a caspase-3-specific Introduction assay, it is now clear that caspases-2 and -7 may also cleave There are a range of different strategies available for prevention this substrate (17) . For this reason, we will here use the less of colorectal cancer (CRC) which involve intervening in specific term DEVD-caspase. Induction of DEVD-caspase 
Materials and methods

RNA extraction and northern blot analysis Materials
For northern blot analysis, cells were seeded at a density of 3-5ϫ10 5 cells/ Major materials and their suppliers were: EDTA, EGTA, herring sperm DNA, well, allowed to attach and grow for 2 days and incubated in the presence or Nonidet P-40 (NP-40), dithiothreitol, sucrose and HEPES (Sigma Chemical absence of 4 mM butyrate. Total RNA was isolated at the indicated times Co., St Louis, MO); sodium butyrate (BDH, Poole, UK); penicillin/streptomyusing the Trizol Reagent (Gibco BRL) according to the manufacturer's cin, EDTA/trypsin, glutamine and CHAPS (ICN, Aurora, OH); gentamicin instructions. Total RNA (10 µg/lane) was electrophoresed in formaldehyde-(David Bull Laboratories, Melbourne, Australia); diphenylamine (Ajax, 1% agarose gels, transferred to Hybond N ϩ nylon membranes (Amersham,
Castle Hill, Australia) and immobilized by UV crosslinking. Membranes were (zDEVD-AFC), zVAD-fmk, z-Val-Ala-Asp-fluoromethyl ketone (zVAD-fmk) pre-hybridized for 3 h at 42°C in 1 M NaCl, 1% SDS, 10% dextran sulfate, and z-Asp-Glu-Val-Asp-fluoromethyl ketone (zDEVD-fmk) (Kamiya Biomed-50% formamide and 100 µg/ml heat-denatured herring sperm DNA. They ical Co., Tukwila, WA). All other reagents were reagent grade, unless indicated.
were then hybridized with p21 WAF1/CIP1 cDNA (a kind gift from Dr Helena
Cell cultures
Richardson, The University of Adelaide, Adelaide, Australia), which was radiolabeled with [α-32 P]dCTP by random priming using the Giga Prime kit LIM 1215 cells were cultured in HEPES-buffered RPMI 1640, pH 7.4 (ICN, (Bresatec, South Australia). To allow quantification of mRNA signals, the Aurora, OH), supplemented with glutamine (2 mM), penicillin (100 IU/ml), same filters were reprobed with a 450 bp 32 P-labeled PCR-generated DNA streptomycin (100 µg/ml), gentamicin (160 µg/ml) and 10% fetal calf serum fragment of human glyceraldehyde 3-phosphate dehydrogenase (GAPDH). (FCS) (Biosciences, Sydney, Australia) in a humidified atmosphere containing Following hybridization for 16 h at 42°C, filters were washed at high 5% CO 2 . Experiments were performed in either 25 cm 2 vented tissue culture stringency and resulting signals analyzed using a SF PhosphorImager (Molecuflasks or 6-well plates (Sarstedt, Newton, NC). LIM 1215 cells were allowed lar Dynamics Inc.). to attach and grow for 2-3 days prior to exposure to test reagents. For cultures with butyrate, stock solutions (400 mM) in RPMI were made fresh each day
Western blotting and diluted into the cell suspension to give the desired final concentration (in Aliquots of cells were lysed in NP-40 lysis buffer (5 mM Tris-HCl, pH 7.5, most experiments this was 1 or 4 mM).
containing 5 mM EDTA, 0.5% NP-40 and complete protease inhibitor cocktail;
Determination of morphological changes in apoptosis
Boehringer Mannheim, Mannheim, Germany) and stored at -20°C until assayed. Protein concentration was measured using the DC protein assay kit For morphological assessment, cells were examined by phase contrast microscopy after addition of an equal volume of 0.2% trypan blue in Hank's (BioRad, Hercules, CA). One volume of 4ϫ SDS loading buffer (250 mM p21 cleavage and butyrate-induced apoptosis Tris-HCl, pH 6.8, 40% v/v glycerol, 8% w/v SDS, 20% v/v 2-mercaptoethanol added for 60 min and secondary antibodies for 45 min at room temperature. Membranes were then soaked in ECL Western Blotting reagent (Amersham and 0.5% w/v bromophenol blue) was added to 3 vol of lysate and mixtures were denatured. Equal protein amounts (18-36 µg) were loaded into wells Life Sciences, Sydney, Australia) and bands detected by autoradiography. Rainbow high molecular weight markers (Amersham Life Sciences) were and electrophoresed on 7.5% minigels for Rb or 12% minigels for p21 (BioRad) at 200 V for 45 min. To ensure that equal amounts of protein were used for determination of molecular weight. loaded in each track, duplicate gels were also stained with Coomassie brilliant Experimental design blue G-250 (BDH, Sydney, Australia). Proteins were blotted onto ImmobilonAll experiments were repeated a minimum of three times. Typical experiments P PVDF membrane (Millipore, Sydney, Australia). Membranes were preare described or data were pooled, as indicated in the text. Statistical blocked with 3% powdered milk in Tris-buffered saline, 0.1% Tween-20, 3% significance was determined by Student's t-test and is indicated in the text or bovine serum albumin for 60 min at room temperature. Primary antibodies legends to figures. used were mouse monoclonal antibodies against human p21 (Clone 6B6, 1/ 333 dilution; Pharmingen) and human Rb (1/333 dilution; Santa Cruz Laboratories) and polyclonal rabbit antibodies against human p27 (1/500 Growth inhibition. LIM 1215 cells were seeded into flasks and treated with physiologically relevant concentrations (0.5-8 mM) of sodium butyrate, 2 days after seeding. They were then assayed at daily intervals for 5 days (days 2-7 after seeding) for changes in adherent cell number (as a measure of viable cells). Figure 1A shows that growth was retarded at all concentrations of butyrate tested, but particularly at concentrations ജ1 mM. Five days after addition of 4 or 8 mM butyrate, cell numbers were significantly lower than those at the time of addition of butyrate. Most of this decrease occurred in the first day after addition. Flow cytometric analysis with propidium iodide showed a progressive depletion of G 1 , S and G 2 ϩ M phase cells, within 30 h after addition of 4 mM butyrate ( Figure 1B, left) . Apoptosis. The decrease in cell numbers at higher concentrations of butyrate suggested that there was not only cell cycle arrest but also cell death. Flow cytometric analysis revealed an increase in apoptotic cells (filled squares in Figure 1B , left), as shown by the appearance of an increasing fraction of cells with less than 2N DNA content, preceding the G 1 peak on the fluorescence scans ( Figure 1B, right) . In contrast, cells treated with 1 mM butyrate failed to undergo apoptosis and the number of cells in the G 1 phase of the cell cycle increased significantly, 48 h post-butyrate treatment, from 59 to 73% ( Figure 1C ). These results suggest that growth inhibition of LIM 1215 cells by low concentrations of butyrate is associated with G 1 arrest, whereas higher concentrations of butyrate such as 4 mM induce apoptosis. Examination of cells treated with 4 mM butyrate, by phase contrast microscopy, showed typical morphological features of apoptosis, including the presence of one or more intracellular apoptotic bodies, a granularity that was often localized to one pole of the cell, exclusion of the vital dye trypan blue, membrane blebbing and, in some cells, reduction in volume. Labeling with acridine orange revealed segmentation of the chromatin into discrete masses in the butyrate-treated cells, compared with the uniform mass of chromatin in untreated cells (not shown). Apoptosis was accompanied by detachment of the cells from the plates. In a typical experiment, incubation of cells for 24 h with 4 mM Figure 1D ). There was little caspase cells when butyrate was added again following this withdrawal period (Ad1'). These changes were accompanied by growth arrest and apoptosis. activity in control cultures, but a marked increase beginning 
Hypophosphorylation of Rb.
There was also a shift in the phosphorylation state of the cell cycle regulator Rb (Figure were no changes in the levels of DEVD-caspase activity (2.7 2). Untreated cells showed the characteristic hypo-phosphoryl-Ϯ 0.8 U/10 5 cells). After this first day, the floating cells in ated Rb and hyper-phosphorylated Rb forms. Disappearance each well were decanted and the remaining adherent cells of phosphorylated Rb was evident by 12-18 h after addition were cultured for a further 24 h with a second application of of butyrate, consistent with inhibition of CDK activity and butyrate (4 mM). Results for this second addition of butyrate cell cycle arrest. The apparent onset of dephosphorylation of are shown in the column marked Ad2. In the presence of Rb is coincident with detectable levels of caspase activation butyrate, there was still high activity of DEVD-caspase (38.7 and apoptosis ( Figure 1D) . . Therefore, in cultures exposed to three cycles of butyrate, remaining attached (and viable) after 24 h with butyrate were subjected to a second and third cycle of treatment with butyrate.
there was selection for a butyrate-resistant subset of LIM 1215 cells. Figure 3A shows the result of a typical experiment (repeated four times) in which total DEVD-caspase activity (expressed To determine whether the resistance to butyrate was permanent, the cells were cultured in the absence of butyrate for 2 per 10 5 cells) from both the adherent and floating cell populations was assayed. The initial level of DEVD-caspase activity days. During this withdrawal period (columns W1 and W2 in Figure 3A ), there was no significant DEVD-caspase activation was 3.0 Ϯ 0.3 U caspase/10 5 cells. The cells were then incubated for 1 day with 4 mM butyrate. There was a substantial over that in control cells. When butyrate was added after the withdrawal period (Ad1'), there was substantial activation of increase in DEVD-caspase activity (60.6 Ϯ 5. Figure 3B shows a correlation between the levels of p21 protein and resistance to butyrate-induced apoptosis. Initially, the cells had moderate levels of p21 protein (lane Ad0). After addition of butyrate for 1 day (lane Ad1), there was a modest increase in p21, in addition to a lower molecular weight band, p15, which is likely to be a cleavage product (see below). After three cycles of addition of 4 mM butyrate and removal of floating cells, the remaining adherent cells, which were resistant to butyrate-induced apoptosis, had very high levels of p21 protein; the p15 band was no longer detectable (lane Ad3). When butyrate was withdrawn, there was a decline in the level of p21. It is interesting to note that the decline in p21 preceded reversal of resistance since at day 1 of withdrawal (lane W1), the cells were still resistant to addition of butyrate (data not shown) but p21 levels had butyrate was re-added after the withdrawal period, the p21
Results were analyzed by densitometry and expressed as a ratio of p21 to level rose again and there was a faint band corresponding to RNA in each track was confirmed by hybridization of the filters with a GAPDH control probe ( Figure 4A , middle). The increase in p21 protein peaked at 9 h after addition of butyrate caspase or another member of the caspase family. In support and was maintained at elevated levels up to, at least, 24 h of this hypothesis, when lysates of the floating non-adherent ( Figure 4B ). As is evident from a comparison of Figures 1D (apoptotic-rich) cell population from 24 h butyrate-treated and 4B, induction of p21 peaked at the time of onset of samples were run individually on western blots, p15 was the activation of DEVD-caspase. predominant fragment ( Figure 4C, lanes c and d) . This suggests Cleavage of p21 is associated with entry into apoptosis in that p21 is entirely cleaved late in apoptosis of CRC cells. On butyrate-treated LIM 1215 cells the other hand, when the lysates of adherent (largely viable or pre-apoptotic) cells were run, both p21 and p15 were detected The p15 band appeared at time points beyond 12 h following addition of 4 mM butyrate and peaked at 24 h ( Figure 4B ).
( Figure 4C , lanes e and f), implying that p21 is cleaved prior to detachment of the cells from the substratum. Lysates of This band was consistently seen in western blots of p21 in butyrate-treated LIM 1215 cells but varied considerably in adherent cells contained significant DEVD-caspase activity (not shown). Note that, despite loading equivalent amounts of intensity. Its first appearance soon after induction of DEVDcaspase in these cells (compare Figure 1D) suggested it may protein in lanes c-f, the p15 band in the lysates of the apoptotic population was much less intense than that of the viable cell be a consequence of proteolytic cleavage of p21 by DEVD- Figure 5B ) and ജ5 µM for zVAD-fmk (filled circles in Figure 5B ), where inhibition of p21 cleavage was only partial, p21 may also be cleaved by other proteases.
Subsequent analysis of the p21 amino acid sequence revealed a likely caspase cleavage motif DHVD between amino acids 109 and 112 ( Figure 6 ). Cleavage after D112 would yield expression of a putative cell death gene which acts synergistically with the Bcl-2-regulated mitochondrial/cytochrome c-mediated pathway (9). These two pathways converge at a population. This may indicate that p15 is degraded further, later in apoptosis. The absence of p15 in lysates of butyratepoint upstream of caspase-3 protease, a major effector of apoptosis. We now show that induction of p21, and its resistant cells, which lacked DEVD-caspase activity ( Figure  3B , lane Ad3) is consistent with the hypothesis that p15 is cleavage, parallel in time these effects and may be critical regulatory events. derived from p21 by caspase cleavage. Somewhat surprisingly, only a very faint p15 band was seen when butyrate was added
The induction of p21 by butyrate in LIM 1215 cells confirms studies in other CRC cell lines (13, 19) and in other types of to these cells after the 2 day withdrawal period (track Ad1'), despite these lysates having equivalent amounts of DEVDcell (20, 21) . LIM 1215 cells have wild-type p53 (25) and are likely to exhibit p53-dependent up-regulation of p21 in caspase activity to those in track Ad1.
Further evidence for a relationship between p15 and caspase response to some stimuli (e.g. DNA-damaging agents). Further induction of p21 by butyrate may be a direct effect mediated cleavage was sought using peptide caspase inhibitors. LIM 1215 cells were pre-treated with either of two peptide inhibitors, by a butyrate-responsive element in the promoter region of the p21 gene (13) . We now show that appearance of p21 the more specific DEVD-caspase inhibitor zDEVD-fmk or the broad spectrum inhibitor zVAD-fmk (both as fluoromethyl immediately precedes the appearance of cytosolic DEVDcaspase activity and onset of DNA fragmentation. p21 was ketone derivatives). The cells were then treated with butyrate and 24 h cell lysates analyzed by western blotting. There was induced during an interval of 3-10 h, previously defined by our cycloheximide inhibition studies for expression of the a consistent decrease in p15 with zDEVD-fmk and zVAD-fmk ( Figure 5A ). Suppression of p15 was more pronounced with essential pro-apoptotic protein (9). This raises the question of whether p21 is this protein or whether it is increased as a zVAD-fmk and the band completely disappeared at a zVADfmk concentration of 100 µM. zDEVD-fmk gave only partial cellular protective mechanism against apoptosis. It seems unlikely that the butyrate-inducible pro-apoptotic protein is inhibition at concentrations up to 100 µM (the highest concentration tested). Cells treated with either zDEVD-fmk alone, p21 since several studies have shown that p21 is anti-apoptotic. For example, antisense oligonucleotides which block p21 zVAD-fmk alone or control cells untreated with butyrate showed no cleavage product ( Figure 5A ). Since DEVD-caspase expression facilitate, rather than suppress, apoptosis in neuroblastoma cells (23). The observed dephosphorylation of hyperactivity in the cells was Ͼ90% suppressed at concentrations phosphorylated Rb, beginning between 6 and 12 h after essential before suicide mechanisms can be turned on. In the absence of p21, DNA-damaged colon cancer cells undergo addition of butyrate to LIM 1215 cells, is in agreement with arrest of these cells in G 1 (26) . It is possible that by maintaining repeated S phases, without intervening mitoses, before dying by apoptosis (34). However, the rapidity of butyrate-induced the cells in G 1 , p21 prevents critical events leading to caspase activation. apoptosis excludes this mechanism for killing of LIM 1215 cells by this agent. We have shown that cleavage of p21 in It is not yet known why some CRC cells differentiate in response to butyrate (3) while others die (7) (8) (9) 27) . The CRC cells precedes apoptotic detachment of cells from the substratum. This event might be important to apoptosis in differentiation pathway is most prominent at 1 mM butyrate (3) while apoptosis is favored at 4 mM (9). However, even at either of two ways. Apoptosis may be allowed to proceed as a result of inactivation of p21 following cleavage, thereby 4 mM butyrate, a significant proportion of cells remained viable. A small proportion of these were killed by a second disrupting its anti-apoptotic action, or, alternatively, the cleavage products themselves might actively promote apoptosis. application of butyrate but no further cell loss occurred with a third cycle of butyrate. Since resistance to butyrate was lost Relevant to this, Prabhu et al. (35) showed that overexpression of a p21 truncation mutant, derived by introduction of a following withdrawal of butyrate for 2 days, a butyrateinducible factor may mediate the resistance to apoptosis. The premature stop codon, in cancer cells induced apoptosis of the cells, whereas wild-type p21 only induced growth arrest. increase in p21 expression in butyrate-resistant cells and its decrease in the absence of butyrate during the withdrawal Coincidentally, the truncation mutant used in those studies terminated at L113, one amino acid beyond the putative phase implicates p21 as that factor.
The detection of an apparent fragment of p21 (designated DHVD-caspase cleavage site. Therefore, induction of apoptosis by overexpression of the caspase-derived fragment seems the p15) at later time points in butyrate-treated LIM 1215 cells was a surprising finding. Recently, the cleavage of p21 during more likely mechanism. p21 is a polypeptide of 164 amino acids with a CDKapoptosis in response to various stimuli has been reported. These include cleavage of p21 in tumor necrosis factor-induced binding site in the N-terminal portion and a PCNA-binding site in the C-terminal portion (18) . The significance of PCNA apoptosis of human cervical carcinoma cells (28) , in growth factor-deprived human endothelial cells (29) and in response binding is unclear. Recently, Lu et al. (36) showed that mutant p21, lacking CDK-inhibitory activity but still retaining PCNA to DNA damage by γ-irradiation and DNA-damaging agents (30, 31) . In support of the hypothesis that the p15 fragment binding, no longer protected a CRC cell line from induction of apoptosis by X-rays or adriamycin, implying that inhibition seen here after butyrate treatment is a caspase cleavage product of p21: (i) p15 began to appear soon after DEVD-caspase was of CDK is critical to p21-mediated suppression of apoptosis. In another study, mutants lacking PCNA binding were unable activated; (ii) it was greatly enriched in the floating apoptotic cell population, but not detected in butyrate-resistant LIM to arrest growth, although apoptosis was not investigated (37) . Since the putative DHVD cleavage motif lies between the 1215 cells; (iii) its appearance was suppressed by peptide caspase inhibitors. That cleavage of p21 is not simply reflecting CDK-cyclin-and PCNA-binding domains (Figure 6 ), cleavage may disrupt the function and/or subcellular localization of p21. wide scale proteolytic degradation is suggested by the presence of a unique caspase-specific motif DHVD in p21 at a position One possibility is that p15, which still retains the CDK-cyclinbinding domain, competes with the remaining p21 for CDK that would correspond to one of the fragments having a molecular weight of~15 kDa. Levkau et al. (29) showed p21 but is unable to inhibit it because PCNA is no longer part of the complex. Alternatively, p15 may fail to localize in the to be an apoptotic substrate which is cleaved at residue L112 and confirmation of this cleavage site was performed by sitenucleus because it lacks PCNA binding. Therefore, expression of p21 and its cleavage are likely to directed mutagenesis. The latter study also showed cleavage of p27 Kip1 in growth factor-deprived endothelial cells, but this have important implications, not only for colorectal tumorigenesis but also for mechanisms of regulation of cell turnover in was not observed in butyrate-treated LIM 1215 cells, suggesting that it may not be essential for apoptosis. The cleavage of p21 normal intestinal epithelium. Expression of p21 WAF1 / CIP1 marks the transition from proliferation to terminal differentiation in by caspases mimics cleavage by these proteases of certain other signal transduction proteins (32).
intestinal epithelium (22). Cleavage of p21 may, in turn, mark the transition from terminal differentiation to apoptosis at the Our data have raised some anomalies regarding the relationship between caspases and cleavage of p21. Firstly, it is of luminal ends of the crypts. The importance of caspase-mediated turnover of p21 versus that of transcriptional regulation now interest to note that when caspase activity was restored in butyrate-resistant cells, following the withdrawal phase ( Figure  needs to be defined. It is possible that cleavage of p21 is a novel regulatory mechanism that facilitates apoptotic death of 3, lane Ad1'), there was only a weak band corresponding to the p15 fragment. We do not fully understand this, however, colon cancer cells by butyrate and perhaps other stimuli. it may reflect differential subcellular localizations of both
